Haile Tecle

This inventor holds 46 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents, primarily in MEK Inhibitors. Top assignee: Warner-Lambert Company. Active years: 1985-2014.

USPTO Granted Patents = 46

% Patents Active = 69.6

CIPO Patents = 3

EPO Patents = 2

Average Co-Inventor Count = 3.3

ph-index = 17

Forward Citations = 764(Granted Patents)

Location History:

Ypsilanti, MI (US) (1993 - 1996)
Ann Arbor, MI (US) (1985 - 2014)

Company Filing History:

46 out of 2,538

Warner-Lambert Company

patents

Years Active: 1985-2014

Loading Chart...

Areas of Expertise:

MEK Inhibitors

Chronic Pain Treatment

Benzamidazoles

Diarylamines

Hydroxamate Esters

Sulfohydroxamic Acids

Benzoheterocycles

Tetrahydropyridine

Azabicyclo Compounds

Muscarinic Agonists

Substituted Tetrazoles

Psychoses Treatment

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8623883 - 4-phenylamino-quinazolin-6-yl-amides (2014-01-07),

2. 8466165 - 4-phenylamino-quinazolin-6-yl-amides (2013-06-18),

3. 7772243 - 4-phenylamino-quinazolin-6-yl-amides (2010-08-10),

4. 7411001 - Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids (2008-08-12),

5. 7169816 - 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors (2007-01-30),

6. 7160915 - N-methyl-substituted benzamidazoles (2007-01-09),

7. 7078438 - N-(4 substituted phenyl)-anthranilic acid hydroxamate esters (2006-07-18),

8. 7030119 - Method for treating chronic pain using MEK inhibitors (2006-04-18),

9. 7019033 - 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives (2006-03-28),

10. 7001905 - Substituted diarylamines as MEK inhibitors (2006-02-21),

11. 6960614 - Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids (2005-11-01),

12. 6891066 - N-(4-substituted phenyl)-anthranilic acid hydroxamate esters (2005-05-10),

13. 6835749 - Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors (2004-12-28),

14. 6821963 - 4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors (2004-11-23),

15. 6750217 - Benzenesulfonamide derivatives and their use as MEK inhibitors (2004-06-15),

Title: The Innovative Journey of Haile Tecle

Introduction: Haile Tecle, a talented inventor based in Ann Arbor, MI, has made significant contributions to the field of technology with his creative solutions and groundbreaking ideas.

Latest Patents: Haile Tecle's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, as well as a novel wearable device for monitoring health metrics in real-time.

Career Highlights: Throughout his career, Haile Tecle has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His work has not only earned him recognition within the industry but has also improved the lives of many through his inventions.

Collaborations: Haile Tecle has collaborated with leading tech companies and research institutions to bring his ideas to life. His partnerships have allowed him to leverage the expertise of others and create truly impactful innovations that push the boundaries of what is possible.

Conclusion: Haile Tecle's passion for innovation and dedication to creating meaningful change through his inventions make him a standout figure in the world of technology. His relentless pursuit of excellence continues to inspire others in the field, shaping the future of innovation for years to come.